CHASE WILLIAM J
SEC insider (Form 3/4/5 filer). CIK 0001563572. Director at GRAIL, Inc. (GRAL) and 1 other issuer. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 15, 2026. Located in SUNNYVALE, CA.
Companies CHASE WILLIAM J has filed insider reports for
- GRAIL, Inc. (GRAL): Director
- Intellia Therapeutics, Inc. (NTLA): Director
CHASE WILLIAM J
CIK: 0001563572
Transaction Breakdown
Open Market Buys (P)1 (6.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)14 (93.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 15, 2026GRAL
GRAIL, Inc.
AwardDirect153 shares at avg. $135.46$21K - Jul 15, 2026GRAL
GRAIL, Inc.
AwardDirect276 shares at avg. $74.36$21K - Jun 18, 2026GRAL
GRAIL, Inc.
AwardDirect5.5K shares at avg. $63.74$350K - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect9.2K shares- - Apr 15, 2026GRAL
GRAIL, Inc.
AwardDirect408 shares at avg. $49.79$20K - Jan 15, 2026GRAL
GRAIL, Inc.
AwardDirect213 shares at avg. $97.44$21K - Oct 15, 2025GRAL
GRAIL, Inc.
AwardDirect275 shares at avg. $75.52$21K - Aug 20, 2025NTLA
Intellia Therapeutics, Inc.
PurchaseDirect100K shares at avg. $10.03$1.0M - Jul 15, 2025GRAL
GRAIL, Inc.
AwardDirect533 shares at avg. $38.53$21K - Jun 11, 2025NTLA
Intellia Therapeutics, Inc.
AwardDirect8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 15, 2026 |  GRAL GRAIL, Inc. | Award | 153 | $135.46 | $20,725 | Direct |
| Jul 15, 2026 | GRAL GRAIL, Inc. | Award | 276 | $74.36 | $20,523 | Direct |
| Jun 18, 2026 | GRAL GRAIL, Inc. | Award | 5,491 | $63.74 | $349,996 | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award | 9,200 | - | $0 | Direct |
| Apr 15, 2026 | GRAL GRAIL, Inc. | Award | 408 | $49.79 | $20,314 | Direct |
| Jan 15, 2026 | GRAL GRAIL, Inc. | Award | 213 | $97.44 | $20,755 | Direct |
| Oct 15, 2025 | GRAL GRAIL, Inc. | Award | 275 | $75.52 | $20,768 | Direct |
| Aug 20, 2025 | NTLA Intellia Therapeutics, Inc. | Purchase | 100,000 | $10.03 | $1,003,000 | Direct |
| Jul 15, 2025 | GRAL GRAIL, Inc. | Award | 533 | $38.53 | $20,536 | Direct |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | Award | 8,000 | - | - | Direct |
1-10 of 15 transactions